Sugammadex is a new reversal agent that rapidly, effectively, safely, and with similar recovery times reverses rocuronium-induced neuromuscular blockade in children, adolescents, adults, and the small number of infants studied.
No takes yet. Share an insight, caveat, or question.
Marwick et al. (2014) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: